Last reviewed · How we verify

NCT03189654

Noninvasive Ventilation Therapy for the Treatment of Pleural Effusion in Patients With Heart Failure

Completed Last updated 30 July 2020
What this trial tests

trial testing Non-invasive ventilation in Pleural Effusion in 11 participants. Completed in 12 March 2020.

Timeline
1 July 2017
Primary endpoint
31 December 2019
12 March 2020

Quick facts

Lead sponsorHeart and Diabetes Center North-Rhine Westfalia
StatusCompleted
Study typeOBSERVATIONAL
Enrollment11
Start date1 July 2017
Primary completion31 December 2019
Estimated completion12 March 2020
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Heart and Diabetes Center North-Rhine Westfalia

Who can join

18 and older, any sex, with Pleural Effusion or Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There are no investigations so far whether an application of positive pressure during non-invasive ventilation might be a therapeutic option for transudative pleural effusion in patients with heart failure. In view of the pathophysiological process with pleural effusion resulting from an increase in intravascular hydrostatic pressure, non-invasive ventilation might provide an improvement. The aim of the present study is to investigate whether an additional non-invasive ventilation therapy leads to an improved suppression of pleural effusion in heart failure patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Non-invasive ventilation

Trials testing the same drug.

Other recruiting trials for Pleural Effusion

Currently open trials in the same condition.

Other Heart and Diabetes Center North-Rhine Westfalia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03189654.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing